Seminars
Mar 24, 2026
PDF Seminar
ER stress disrupts hypertrophic chondrocytes plasticity, impairing trabecular organization and vascularization - Dr. Xiaodan Yu (Post-doctoral Fellow)
School of Biomedical Sciences cordially invites you to join the following Post-doctoral Fellow (PDF) Seminar:
Date: 24 March 2026 (Tuesday)
Time: 4:00 pm – 4:30 pm
Venue: Seminar Room 2, G/F, Laboratory Block, 21 Sassoon Road
Host: Dr. Xiang Fang & Dr. Yolanda Liu
Light refreshments will be served. Please register via the below link by 23 March 2026 (Monday):
Registration: https://hku.au1.qualtrics.com/jfe/form/SV_e8QWxQGhsb8vuTA
ER stress disrupts hypertrophic chondrocytes plasticity, impairing trabecular organization and vascularization
Dr. Xiaodan Yu (Post-doctoral Fellow)
[Supervisor: Professor Kathryn Cheah]
The cellular dynamics of the bone remodeling niche are critical for homeostasis and repair. Hypertrophic chondrocytes (HCs) contribute to osteoblasts, but their plasticity under stress remains undefined. Here, we integrate single-cell and spatial transcriptomics in an MCDS mouse model (13del mice) to decode HC fate under ER stress. Stressed HCs revert to a pre-hypertrophic-like state with disrupted differentiation, impairing contribution to osteoblast and skeletal stem/progenitor lineages. This disorganizes trabecular structure, coupled with abnormal osteoclast distribution and disrupted type H vessel formation. Mechanistically, unresolved ER stress upregulates Serpinf1 and induces ectopic SOX9 expression in trabecular bone. Genetic removal of Sox9 in HCs partially restores differentiation and bone formation, while Atf4 overexpression phenocopies this disruption. Our findings establish ER stress as a regulator of HC plasticity, defining a "lineage stress" mechanism underlying skeletal disorders and identifying the ER stress-SOX9 axis as a potential therapeutic target.
All are welcome.
New Releases
Mar 9, 2026
HKUMed demonstrates that 'cloaked' and safe human stem cells work, paving the way for off-the-shelf transplants without immune rejection
Feb 11, 2026
HKUMed School of Biomedical Sciences and Merck Pharmaceutical (Hong Kong) sign MoU to advance biomedical education and talent development
Nov 25, 2025
HKUMed cracks gastric cancer’s ‘metabolic code’: Tumour growth slowed by 65%, plus a 6.3-fold kill rate with cholesterol inhibitors in neuron-infiltrated cases
Nov 6, 2025